The global organ preservation market size was estimated at USD 273.0 million in 2024 and is projected to grow at a CAGR of 6.5% from 2025 to 2030. Market growth is driven by key factors such as increasing demand for organ transplants, technological advancements, an aging population, and proactive government initiatives. The United Network for Organ Sharing reported that in 2022, the U.S. performed 42,887 organ transplants, reflecting a 3.7% increase from the previous year. This upward trend is primarily attributed to rising rates of organ failure linked to chronic diseases such as diabetes and hypertension, creating an urgent need for effective preservation solutions that ensure the viability of organs during transportation and storage.
Technological innovations are also pivotal in advancing the organ preservation landscape. Improvements in machine perfusion techniques have shown promising results in increasing organ survival rates. These advancements demonstrate a commitment to innovation within the preservation methods and ensure successful transplantation outcomes, attracting investments and further igniting interest in the market.
According to the U.S. Census Bureau, it is projected that 20% of the U.S. population will be aged 65 and older by 2024, leading to a higher incidence of age-related diseases necessitating organ transplants. This significant increase in the elderly population will intensify the demand for effective preservation solutions, particularly for kidney, liver, and heart transplants, as more elderly patients require these critical procedures.
Government initiatives further bolster the organ preservation market by enhancing organ donation rates through awareness campaigns and funding. For instance, in February 2023, the Indian Express reported that the Brihanmumbai Municipal Corporation (BMC) in India allocated approximately USD 924 million to improve healthcare services and promote organ donation awareness. Such governmental support is vital in driving the need for efficient preservation methods, particularly in emerging markets such as the Asia Pacific, where healthcare expenditures are rising. This convergence of factors is preparing the organ preservation industry for substantial growth in the coming years.
University of Wisconsin (UW) dominated the market and accounted for a share of 36.0% in 2024. The UW solution greatly extended preservation durations for organs such as kidneys and livers. Recent enhancements, which incorporate natural trophic factors, have further optimized its efficacy, enabling longer storage with reduced injury, thereby addressing the shortage of transplantable organs and enhancing transplant success rates.
Perfadex is expected to grow at the fastest CAGR of 7.4% over the forecast period, fueled by Perfadex’s proven effectiveness in lung preservation, which significantly lessens reperfusion injury and enhances graft viability. Designed specifically for lung transplants, Perfadex minimizes edema and improves functional performance during ischemia, resulting in superior organ quality and reduced acute graft failure rates for transplant recipients.
The static cold storage segment held the largest share of 45.1% in 2024, attributed to the simplicity and effectiveness of the SCS preservation technique, which has been standard for over 50 years. This method minimizes cellular metabolism and maintains organ viability through cold preservation solutions and ice storage, ensuring successful kidney transplantation outcomes while addressing organ ischemia challenges.
Normothermic machine perfusion is projected to grow at the fastest CAGR of 7.2% over the forecast period. NMP maintains organs in a metabolically active state, enhancing viability before transplantation. This technique enables real-time assessment of organ function and rehabilitation through nutrient infusion, reducing ischemia-reperfusion injury. NMP has demonstrated promising outcomes for marginal organs, expanding the donor pool and improving transplant success rates.
Kidneys led the market with a revenue share of 34.5% in 2024, supported by the rising incidence of ESRD and chronic conditions such as diabetes and hypertension. As kidneys remain the most frequently transplanted organs, the critical shortage of donor kidneys underscores the necessity for effective preservation methods to enhance viability during transportation and storage.
The heart segment is expected to register the fastest growth of 6.8% over the forecast period. As heart transplant rates increase with the rising prevalence of coronary artery disease and heart failure, the importance of effective preservation methods escalates. Advanced preservation techniques improve organ viability during transport, facilitating better outcomes for transplant recipients and addressing the critical shortage of donor hearts in transplantation programs.
North America organ preservation market dominated the global market with a revenue share of 45.3% in 2024. The region boasts enhanced healthcare infrastructure, substantial investments in research and development, and increasing organ transplant rates. Strong governmental support for organ donation initiatives and innovative preservation techniques further improve organ viability and transplant success rates, effectively addressing the rising demand for transplantation.
The organ preservation market in the U.S. dominated the North America organ preservation market with the largest revenue share in 2024. With around 40,000 organ transplants conducted each year, advances in preservation technologies and robust public awareness campaigns significantly boost the demand for effective preservation solutions, ultimately ensuring improved outcomes for transplant recipients and enhancing the overall efficiency of the transplantation process.
Europe organ preservation market held substantial market share in 2024. The region is supported by strong regulatory frameworks that promote organ donation and transplantation, coupled with continuous research into advanced preservation techniques. These efforts enhance organ viability and ultimately lead to improved patient outcomes in the transplantation process.
The organ preservation market in Germany is expected to grow in the forecast period. The country has experienced an increase in organ transplant procedures, bolstered by government initiatives that promote organ donation. Furthermore, advancements in preservation techniques are significantly enhancing the viability of donated organs, thereby contributing to improved success rates in transplantation outcomes.
Asia Pacific organ preservation market is expected to register the fastest CAGR of 6.1% in the forecast period. The region is witnessing heightened healthcare investments alongside a growing population affected by chronic diseases. Increased awareness of organ donation and transplantation, combined with advancements in preservation technologies, is driving demand. Furthermore, the expanding healthcare infrastructure enhances access to organ preservation solutions, addressing the urgent need for effective transplant options.
The organ preservation market in India is expected to register the fastest growth in the Asia Pacific market over the forecast period. Government initiatives aimed at enhancing healthcare services and promoting organ transplantation are pivotal in driving market growth. Moreover, improvements in preservation techniques are increasing the viability of organs during transport, effectively addressing the rising demand for successful transplant outcomes within the country.
Some key companies operating in the market include XVIVO; TransMedics, Inc.; 21st Century Medicine; Bridge to Life Ltd.; Preservation Solutions, Inc.; among others. Key players are implementing strategies including mergers, acquisitions, and partnerships to strengthen market presence. Initiatives focus on innovative preservation solutions and expansion into emerging markets to enhance organ viability and transplant success rates.
TransMedics, Inc. specializes in advanced organ preservation technologies, particularly the Organ Care System (OCS), facilitating normothermic perfusion of donor hearts, lungs, and livers. This system enhances organ viability and enables real-time quality assessment prior to transplantation.
Preservation Solutions, Inc. specializes in the development and manufacturing of organ transplantation preservation solutions. Their flagship product, the University of Wisconsin (UW) solution, is extensively utilized for kidney preservation, enhancing organ viability during storage and transport.
The following are the leading companies in the organ preservation market. These companies collectively hold the largest market share and dictate industry trends.
View a comprehensive list of companies in the Organ Preservation Market.
In November 2024, XVIVO completed enrollment for the PRESERVE clinical trial, evaluating their heart technology’s safety and effectiveness, achieving this milestone five months ahead of schedule with 141 patients transplanted.
In October 2024, Bridge to Life and ULS Coimbra announced a collaboration to enhance liver preservation for transplantation, launching case studies to highlight innovative procedures at ULS Coimbra’s liver transplant program.
In August 2024, Getinge announced the acquisition of Paragonix Technologies for approximately USD 477 million, enhancing its position in the organ preservation and transportation market while expanding its product portfolio.
Report Attribute |
Details |
Market size value in 2025 |
USD 291.2 million |
Revenue forecast in 2030 |
USD 411.7 million |
Growth rate |
CAGR of 6.5% from 2025 to 2030 |
Base year for estimation |
2024 |
Historical data |
2018 - 2023 |
Forecast period |
2025 - 2030 |
Quantitative units |
Revenue in USD million and CAGR from 2025 to 2030 |
Report coverage |
Revenue forecast, company ranking, competitive landscape, growth factors, trends |
Segments covered |
Solution, organ type, preservation technique, region |
Regional scope |
North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
Country scope |
U.S., Canada, Mexico, UK, Germany, France, Italy, Spain, Denmark, Sweden, Norway, China, Japan, India, Australia, South Korea, Thailand, Brazil, Argentina, South Africa, Saudi Arabia, UAE, Kuwait |
Key companies profiled |
XVIVO; TransMedics, Inc.; 21st Century Medicine; Bridge to Life Ltd.; Preservation Solutions, Inc.; Global Transplant Solutions; Organ Recovery Systems; CryoLife, Inc. (Artivion, Inc); Paragonix Technologies, Inc (Getinge) |
Customization scope |
Free report customization (equivalent up to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope. |
Pricing and purchase options |
Avail customized purchase options to meet your exact research needs. Explore purchase options |
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the global organ preservation market report based on solution, organ type, preservation technique, and region:
Solution Outlook (Revenue, USD Million, 2018 - 2030)
University of Wisconsin (UW)
Custodiol HTK
Perfadex
Others
Organ Type Outlook (Revenue, USD Million, 2018 - 2030)
Kidneys
Liver
Lung
Heart
Others
Preservation Technique Outlook (Revenue, USD Million, 2018 - 2030)
Static Cold Storage
Hypothermic Machine Perfusion
Normothermic Machine Perfusion
Others
Regional Outlook (Revenue, USD Million, 2018 - 2030)
North America
U.S.
Canada
Mexico
Europe
UK
Germany
France
Italy
Spain
Denmark
Sweden
Norway
Asia Pacific
Japan
China
India
Australia
South Korea
Thailand
Latin America
Brazil
Argentina
Middle East & Africa
South Africa
Saudi Arabia
UAE
Kuwait
NEED A CUSTOM REPORT?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities. Contact us now
We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.
"The quality of research they have done for us has been excellent."